Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Sugar

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Contemporary Clinical Trials|October 15, 2014
The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosisPavan Bhargava, Sandra Cassard, Sonya U Steele, et al.
Annals of the American Thoracic Society|June 5, 2018
Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down TherapyEmily DiMango, Linda Rogers, Joan Reibman, et al.
Ophthalmology|August 16, 2011
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial, John H Kempen, Michael M Altaweel, et al.
Ophthalmology|August 24, 2015
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study, John H Kempen, Michael M Altaweel, et al.
American Journal of Ophthalmology|January 10, 2016
Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up StudyJanet T Holbrook, Elizabeth A Sugar, Alyce E Burke, et al.
Ophthalmology|August 3, 2012
Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndromeJohn H Kempen, Elizabeth A Sugar, Alice T Lyon, et al.
Ophthalmology|August 12, 2014
Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infectionsJohn H Kempen, Elizabeth A Sugar, Rohit Varma, et al.
BMC Pulmonary Medicine|August 3, 2023
"It's a cause I believe in": factors motivating participation and engagement in longitudinal, respiratory-focused research studiesAndrew J Synn, Katherine E Menson, Mercedes R Carnethon, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 28, 2011
Risk factors for montelukast treatment failure in step-down therapy for controlled asthmaM Bradley Drummond, Stephen P Peters, Mario Castro, et al.
International Journal of Cancer|March 14, 2007
Six-month natural history of oral versus cervical human papillomavirus infectionGypsyamber D'Souza, Carole Fakhry, Elizabeth A Sugar, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Contemporary Clinical Trials|October 15, 2014
The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosisPavan Bhargava, Sandra Cassard, Sonya U Steele, et al.
Annals of the American Thoracic Society|June 5, 2018
Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down TherapyEmily DiMango, Linda Rogers, Joan Reibman, et al.
Ophthalmology|August 16, 2011
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial, John H Kempen, Michael M Altaweel, et al.
Ophthalmology|August 24, 2015
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study, John H Kempen, Michael M Altaweel, et al.
American Journal of Ophthalmology|January 10, 2016
Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up StudyJanet T Holbrook, Elizabeth A Sugar, Alyce E Burke, et al.
Ophthalmology|August 3, 2012
Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndromeJohn H Kempen, Elizabeth A Sugar, Alice T Lyon, et al.
Ophthalmology|August 12, 2014
Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infectionsJohn H Kempen, Elizabeth A Sugar, Rohit Varma, et al.
BMC Pulmonary Medicine|August 3, 2023
"It's a cause I believe in": factors motivating participation and engagement in longitudinal, respiratory-focused research studiesAndrew J Synn, Katherine E Menson, Mercedes R Carnethon, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 28, 2011
Risk factors for montelukast treatment failure in step-down therapy for controlled asthmaM Bradley Drummond, Stephen P Peters, Mario Castro, et al.
International Journal of Cancer|March 14, 2007
Six-month natural history of oral versus cervical human papillomavirus infectionGypsyamber D'Souza, Carole Fakhry, Elizabeth A Sugar, et al.
Pageof 8